Baijin Life Science Holdings (HKSE:01466) Scaled Net Operating Assets : 0.65 (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Baijin Life Science Holdings Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Baijin Life Science Holdings's operating assets for the quarter that ended in Sep. 2024 was HK$192.33 Mil. Baijin Life Science Holdings's operating liabilities for the quarter that ended in Sep. 2024 was HK$63.55 Mil. Baijin Life Science Holdings's Total Assets for the quarter that ended in Mar. 2024 was HK$196.80 Mil. Therefore, Baijin Life Science Holdings's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.65.

Baijin Life Science Holdings Scaled Net Operating Assets Historical Data

The historical data trend for Baijin Life Science Holdings's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baijin Life Science Holdings Scaled Net Operating Assets Chart

Baijin Life Science Holdings Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.32

0.34

0.48

0.49

1.26

Baijin Life Science Holdings Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.80	0.40	0.38	1.28	0.65

Competitive Comparison of Baijin Life Science Holdings's Scaled Net Operating Assets

For the Luxury Goods subindustry, Baijin Life Science Holdings's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Baijin Life Science Holdings's Scaled Net Operating Assets Distribution in the Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Baijin Life Science Holdings's Scaled Net Operating Assets falls into.

Baijin Life Science Holdings Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Baijin Life Science Holdings's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Mar. 2024 )
=	(Operating Assets (A: Mar. 2024 )	-	Operating Liabilities (A: Mar. 2024 ))	/	Total Assets (A: Mar. 2023 )
=	(158.918	-	32.817)	/	99.851
=	1.26

where

	Operating Assets		(A: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	196.802	-	37.884
=	158.918

	Operating Liabilities		(A: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	84.01	-	40.66	-	10.533
=	32.817

Baijin Life Science Holdings's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2024 )
=	(Operating Assets (Q: Sep. 2024 )	-	Operating Liabilities (Q: Sep. 2024 ))	/	Total Assets (Q: Mar. 2024 )
=	(192.325	-	63.547)	/	196.802
=	0.65

where

	Operating Assets		(Q: Sep. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	236.695	-	44.37
=	192.325

	Operating Liabilities		(Q: Sep. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	129.259	-	52.995	-	12.717
=	63.547

Baijin Life Science Holdings Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Baijin Life Science Holdings's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Baijin Life Science Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Baijin Life Science Holdings Ltd (HKSE:01466) » Definitions » Scaled Net Operating Assets

Traded in Other Exchanges

MNNGF:USA

Address

66 Gloucester Road, Office B, 9/F Pico Tower, Wanchai, Hong Kong, HKG

Website

http://www.affluent-partners.com

Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company produces health products that are affordable for the general public. The business segments of the company are Life Science segment which includes cellular technology-based services, provide including cellular drugs R&D, large molecule drugs R&D, clinical research services and R&D and sales on self-owned skincare brand, and Fine Jewelry segment that focuses on the procurement, processing, design, production and wholesale distribution of pearls and fine jewelry products.

Executives

Pacific Wish Limited
Chan Vincent Wing Sing
Hui Ka Man Emily
Su Yaoyao	2201 Interest of corporation controlled by you
Ketto Inform Limited	2101 Beneficial owner

Baijin Life Science Holdings Headlines

No Headlines